Zhenyu Wu

1.8k total citations
49 papers, 652 citations indexed

About

Zhenyu Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Zhenyu Wu has authored 49 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 12 papers in Cancer Research and 8 papers in Oncology. Recurrent topics in Zhenyu Wu's work include Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Ferroptosis and cancer prognosis (6 papers). Zhenyu Wu is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (7 papers) and Ferroptosis and cancer prognosis (6 papers). Zhenyu Wu collaborates with scholars based in China, United States and Australia. Zhenyu Wu's co-authors include Lifu Wang, Xi Sun, Lingling Wang, Jiaying Li, Yan‐Lai Tang, Michael S. Roberts, B. Mark Smithers, Fuchang Li, Yanli Zhu and Nan Wang and has published in prestigious journals such as Scientific Reports, Ophthalmology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Zhenyu Wu

42 papers receiving 644 citations

Peers

Countries citing papers authored by Zhenyu Wu

Since Specialization

Citations

This map shows the geographic impact of Zhenyu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Wu more than expected).

Fields of papers citing papers by Zhenyu Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Wu. The network helps show where Zhenyu Wu may publish in the future.

Co-authorship network of co-authors of Zhenyu Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenyu Wu. A scholar is included among the top collaborators of Zhenyu Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenyu Wu. Zhenyu Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical and pilot clinical evaluation of novel dual-modality pet/fluorescence probes targeting FAP for accurate tumor margin delineation 2025 ·European Journal of Nuclear Medicine and Molecular Imaging ·Liang Zhao, Yizhen Pang, Daqiang Xu, Jianhao Chen, Shan Yu, Dan Ruan, (unknown), Zhenyu Wu, Guoqiang Su, Hua Wu, Lin Ai, Long Sun, Di Fan, Haojun Chen	0
2	Association of cardiometabolic index and depressive symptoms with cardiovascular and cerebrovascular diseases in middle-aged and older adults: A national prospective cohort study 2025 ·Journal of Affective Disorders ·(unknown), (unknown), (unknown), Zhenyu Wu, Ying Gao, (unknown), Qing Zhang, Liang Wang, Xinyu Yang	0
3	Molybdenum-bridged endo-exogenous antioxidant synergy reverses acute kidney injury via mitochondrial homeostasis reconstruction 2025 ·Bioactive Materials ·Qiaohui Chen, Zuoxiu Xiao, (unknown), (unknown), Jianlin Chen, Zhenyu Wu, (unknown), (unknown), Yayun Nan, Qiong Huang, Kelong Ai	0
4	Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model 2023 ·Frontiers in Oncology ·Yaxuan Liu, Zhenyu Wu, (unknown), Jiawei Gao, Bo Wang, Changlin Lian, Bo Diao	11
5	Development and validation of an endoplasmic reticulum stress long non-coding RNA signature for the prognosis and immune landscape prediction of patients with lung adenocarcinoma 2023 ·Frontiers in Genetics ·Jie Zeng, Zhenyu Wu, (unknown), Xie George Xu, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	6
6	Multi-omics analysis reveals the association between elevated KIF18B expression and unfavorable prognosis, immune evasion, and regulatory T cell activation in nasopharyngeal carcinoma 2023 ·Frontiers in Immunology ·Siqi Tang, Zhenyu Wu, Lusi Chen, (unknown), (unknown), Weijun Luo, Yang Zhang, Shaoqiang Liang, (unknown), (unknown), (unknown), Ning Zhang	4
7	Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma 2023 ·Frontiers in Oncology ·Mengxi Wu, Zhenyu Wu, (unknown), Jie Zeng, (unknown), (unknown), Xiaojia Zhu, (unknown), Quanwei Guo, Dongfang Li, (unknown), Tao Zhang, Jianhua Zhang	1
8	Clinicopathological significance and prognostic value of cancer-associated fibroblasts in prostate cancer patients 2021 ·Urologic Oncology Seminars and Original Investigations ·Zhenyu Wu, Juanyi Shi, (unknown), Kaiwen Li, Kuiqing Li, Zhuohang Li, Zhuang Tang, Cheng Liu, Kewei Xu	20
9	Early single-dose exosome treatment improves neurologic outcomes in a 7-day swine model of traumatic brain injury and hemorrhagic shock 2020 ·The Journal of Trauma: Injury, Infection, and Critical Care ·Aaron M. Williams, Zhenyu Wu, Umar F. Bhatti, Ben E. Biesterveld, Michael T. Kemp, Glenn K. Wakam, (unknown), Kiril Chtraklin, (unknown), (unknown), Simone E. Dekker, Yuzi Tian, Baoling Liu, Yongqing Li, Benjamin Buller, Hasan B. Alam	37
10	Annual glycemic variations and risk of cancer among Chinese patients with type 2 diabetes mellitus: A population-based cohort study in Shanghai 2020 ·Diabetes Research and Clinical Practice ·Huilin Xu, Fen Zhang, Wanghong Xu, Jun Li, Jingjing Zhu, Minlu Zhang, Zhenyu Wu, Guoyou Qin	4
11	Relative Levels of NKX2-1 and the Long-Noncoding RNA NKX2-1-AS1 Regulate Expression of Immune Evasion Genes in Lung Cancer 2019 ·María I. Ramirez, Guetchyn Millien, (unknown), Zhenyu Wu, Freddy Romero, Ross Summer, Hasmeena Kathuria	1
12	Extracellular Vesicle-Mediated Communication Within Host-Parasite Interactions 2019 ·Frontiers in Immunology ·Zhenyu Wu, (unknown), Lingling Wang, Jiaying Li, Lifu Wang, (unknown), (unknown), Xi Sun	126
13	Hepatitis B virus-persistent infection and innate immunity defect: Cell-related or virus-related? 2018 ·World Journal of Clinical Cases ·(unknown), Zhenyu Wu, (unknown), Jing Ma, Guozhong Gong	3
14	Parasite-Derived Proteins for the Treatment of Allergies and Autoimmune Diseases 2017 ·Frontiers in Microbiology ·Zhenyu Wu, Lifu Wang, Yan‐Lai Tang, Xi Sun	56
15	Pretreatment neutrophil-to-lymphocyte ratio and its dynamic changes are associated with the overall survival in advanced cancer patients undergoing palliative care 2016 ·Scientific Reports ·Weiwei Zhao, Zhenyu Wu, Yintao Li, Huixun Jia, (unknown), Xiaoli Gu, Minghui Liu, Zhe Zhang, Peng Wang, Wenwu Cheng	18
16	miR-124-3p functions as a tumor suppressor in breast cancer by targeting CBL 2016 ·BMC Cancer ·Yanbo Wang, (unknown), Zhenyu Wu, Minghai Wang, Fangfang Jin, Nan Wang, Xiuting Hu, Zhengya Liu, Chen‐Yu Zhang, Ke Zen, Jiangning Chen, Hongwei Liang, Yujing Zhang, Xi Chen	86
17	[The protective mechanism study of fengshiqing recipe against bone destruction in CIA rats]. 2013 ·PubMed ·Quan Jiang, (unknown), Wei Cao, (unknown), (unknown), Yun Lei, Jiaxiu Li, (unknown), Bo Gao, (unknown), (unknown), Huaqiang Zhai, Zhenyu Wu	0
18	Errors in Retinal Thickness Measurements Obtained by Optical Coherence Tomography 2006 ·Ophthalmology ·Srinivas R. Sadda, Zhenyu Wu, Alexander C. Walsh, (unknown), (unknown), (unknown), L. LaBree	18
19	Can tissue drug concentrations be monitored by microdialysis during or after isolated limb perfusion for melanoma treatment? 2000 ·Melanoma Research ·Zhenyu Wu, B. Mark Smithers, Christopher D. Anderson, Michael S. Roberts	8
20	High-performance liquid chromatographic assay for the measurement of melphalan and its hydrolysis products in perfusate and plasma and melphalan in tissues from human and rat isolated limb perfusions 1995 ·Journal of Chromatography B Biomedical Sciences and Applications ·Zhenyu Wu, (unknown), Michael S. Roberts, Russell S. Addison, G. R. Cannell, Anthony J. Grabs, B. Mark Smithers	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact